| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 234,476 | 296,274 | 229,123 | 414,074 | | Cost of Revenue | 29,959 | 38,387 | 44,067 | 32,178 | | | Gross Profit | 204,517 | 257,887 | 185,056 | 381,896 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 68,922 | 69,315 | 97,949 | 52,621 | | Non Recurring |
-
|
-
| 158,574 | (73,016) | | Others | 212,685 | 164,231 | 327,736 | 245,960 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (77,090) | 24,341 | (399,203) | 156,331 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,606 | (89,438) |
-
|
-
| | Earnings Before Interest And Taxes | (74,484) | (65,097) | (399,149) | 156,431 | | Interest Expense | 80,906 | 92,648 | 138,519 | 148,318 | | Income Before Tax | (155,390) | (157,745) | (537,668) | 8,113 | | Income Tax Expense | 91,179 | (53,425) | (240,158) | 58 | | Minority Interest | 22 | 16 | 54 | 100 | | | | Net Income From Continuing Ops | (246,547) | (104,304) | (297,510) | 8,055 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (246,547) | (104,304) | (297,510) | 8,055 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($246,547) | ($104,304) | ($297,510) | $8,055 |
|
0.01% Nasdaq 
0.02 (0.51%) 
Income Statement
